The majority are in the very early preclinical stage of development, but applications for regulatory approval have been ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program to ...

The gene therapy Casgevy, which will now be offered to some patients in England, could help people live disease-free, experts ...

AI could deliver substantially greater efficiencies in cell and gene therapy manufacturing and enable more patients to ...

A £1.65 million treatment has been approved for use for some NHS patients, offering some with an inherited blood disorder ...

The therapy involves taking stem cells out of a patient's bone marrow and editing a gene in the cells in a laboratory and ...

BOISE — Sen. Brandon Shippy, R-New Plymouth, is proposing to put a 10-year pause on certain types of vaccines that were used ...

People in England to benefit from groundbreaking one-off gene therapy for severe sickle cell disease approved by NICE ...

The UK’s Medicines and Healthcare Regulatory Agency (MHRA) approved Casgevy for sickle cell disease in 2023, followed by ...

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

The National Institute for Health and Care Excellence (NICE) has approved a one-off gene editing therapy to treat severe sickle cell disease (SCD) in people 12 years and over. In final draft guidance1 ...